Loading...
Domestic
Equity
Passive

KBSTAR Healthcare (253280)

Update : 2023.05.29

NAV

11,388KRW

-0.03하락 (-%)

Market Price per share (KRW)

11,355KRW

+10상승 (0.09%)

※ t-1 last price

trading volume

1,425shares

AUM

KRW 5.6billion

KBSTAR Healthcare (253280)

KEY POINT

Invest in domestic healthcare companies (medical equipment and services, bio, pharmaceutical)

KEY POINT

Invest in selected healthcare companies based on financial conditions among the top 500 companies by market capitalization of the KOSPI and KOSDAQ markets

Basic information

Download trading information

Update : 2023.05.29
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB KStar V&S Select ValueETF(Equity)
(253280)
FnGuide HealthCare Index 2016.09.23 50,000 5,694,125,418
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 11,355
※ t-1 last price
11,388 1,425
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency 다운로드 버튼
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%) Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB KStar V&S Select ValueETF(Equity)

(253280)
FnGuide HealthCare Index
Inception date Creation Unit
2016.09.23 50,000
AUM(0.1 billion) (KRW) Trustee
5,694,125,418 하나은행
Market Price per share (KRW) iNAV per share (KRW)
11,355
※ t-1 last price
11,388
Trading Volume (shares)
1,425
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%)
Distribution Frequency
Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Index is a market capitalization weighted index. The index selects stocks that satisfy financial and management soundness criteria out of the universe of stocks come under the medical sector in the MKF 500.

View detailed index information

TOP 10 Holdings

Update : 2023-05-29
Rank , Name, proportion table
Rank Name Weight (%)
1 Celltrion Healthcare 10.87
2 Celltrion 9.35
3 HLB 9.06
4 SAMSUNG BIOLOGICS 8.67
5 Yuhan 7.45
6 HanmiPharm 5.24
7 SKBP 4.57
8 SKBS 3.94
9 Celltrionph 3.68
10 MedyTox 2.81

proportion by sectors

*The proportion of investment stocks

Update : 2023.05.29
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 100.00

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2023-04-28 2023-05-03 16
2022-04-29 2022-05-03 60
2021-04-30 2021-05-04 71
2020-04-29 2020-05-06 46

Performance

performance

excel download

Update : 2023-05-29

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)
Since
inception
NAV 1.99 12.03 9.72 -3.03 1.18 9.98 12.12
Benchmark Index 2.02 12.19 9.45 -3.54 1.25 10.17 12.77
Outperformance -0.04 -0.17 0.27 0.51 -0.08 -0.19 -0.66

daily Performance

excel download

date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2023.05.26 11,355 0.088상승 11,325.61 -1.843하락
2023.05.25 11,345 -1.774하락 11,538.27 -0.818하락
2023.05.24 11,550 -0.773하락 11,633.52 1.326상승
2023.05.23 11,640 1.526상승 11,481.26 1.434상승
2023.05.22 11,465 1.550상승 11,318.85 -
2023.05.19 11,290 0.579상승 11,210 -1.741하락
2023.05.18 11,225 -1.362하락 11,408.65 2.905상승
2023.05.17 11,380 2.939상승 11,086.5 -0.379하락
2023.05.16 11,055 -0.718하락 11,128.68 0.128상승
2023.05.15 11,135 0.179상승 11,114.38 -
2023.05.12 11,115 -0.803하락 11,191.4 -1.233하락
2023.05.11 11,205 -1.234하락 11,331.12 -0.675하락
2023.05.10 11,345 -0.569하락 11,408.21 0.943상승
2023.05.09 11,410 0.973상승 11,301.54 -2.061하락
2023.05.08 11,300 -1.781하락 11,539.4 -
2023.05.04 11,505 3.369상승 11,145.21 -1.243하락
2023.05.03 11,130 -1.504하락 11,285.6 1.066상승
2023.05.02 11,300 1.163상승 11,166.46 -

Holdings

Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares
/ Par value
Weight(%) Market price (KRW)
1 Celltrion Healthcare KR7091990002 836 10.87 61,529,600
2 Celltrion KR7068270008 306 9.35 52,968,600
3 HLB KR7028300002 1,437 9.06 51,300,900
4 SAMSUNG BIOLOGICS KR7207940008 63 8.67 49,077,000
5 Yuhan KR7000100008 711 7.45 42,162,300
6 HanmiPharm KR7128940004 99 5.24 29,650,500
7 SKBP KR7326030004 362 4.57 25,883,000
8 SKBS KR7302440003 282 3.94 22,334,400
9 Celltrionph KR7068760008 242 3.68 20,812,000
10 MedyTox KR7086900008 69 2.81 15,904,500
11 BIONEER KR7064550007 295 2.69 15,251,500
12 DENTIUM KR7145720009 87 2.42 13,719,900
13 Hanmi Science KR7008930000 362 2.33 13,213,000
14 SEEGENE KR7096530001 483 2.06 11,664,450
15 ST Pharm KR7237690003 133 2.04 11,531,100
16 SCD KR7000250001 180 1.99 11,286,000
17 HANALL BIOPHARMA KR7009420001 469 1.81 10,247,650
18 GC Corp KR7006280002 73 1.61 9,139,600
19 PharmaResearch KR7214450009 80 1.6 9,080,000
20 SD Biosensor KR7137310009 482 1.46 8,280,760
21 원화예금 KRD010010001 8,027,147 1.42 8,027,147
22 CHA Biotech KR7085660009 528 1.4 7,925,280
23 ShinpoongPharm KR7019170000 440 1.35 7,638,400
24 Lutronic KR7085370005 276 1.24 7,010,400
25 DAEWOONG PHARM KR7069620003 60 1.19 6,762,000
26 HK inno.N KR7195940002 193 1.14 6,465,500
27 CLASSYS KR7214150005 229 1.02 5,793,700
28 Jeisys Medical KR7287410005 660 1.01 5,728,800
29 HUMASIS KR7205470008 1,568 0.84 4,766,720
30 GC CELL KR7144510005 105 0.82 4,662,000
31 ILDONG PHARM KR7249420001 215 0.76 4,297,850
32 Boryung KR7003850005 392 0.62 3,488,800
33 YUNGJIN PHARM KR7003520004 1,194 0.61 3,438,720
34 KUP KR7033270000 119 0.48 2,737,000
35 KUKJEON KR7307750000 254 0.28 1,612,900
36 KOREA PHARMA KR7032300006 45 0.16 888,750
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.